These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19902332)

  • 1. Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants.
    Piecha D; Weik J; Kheil H; Becher G; Timmermann A; Jaworski A; Burger M; Hofmann MW
    Inflamm Res; 2010 May; 59(5):379-89. PubMed ID: 19902332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor.
    Attur M; Al-Mussawir HE; Patel J; Kitay A; Dave M; Palmer G; Pillinger MH; Abramson SB
    J Immunol; 2008 Oct; 181(7):5082-8. PubMed ID: 18802112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
    Yasuda T; Poole AR
    Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.
    Chubinskaya S; Huch K; Mikecz K; Cs-Szabo G; Hasty KA; Kuettner KE; Cole AA
    Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New hope for the treatment of osteoarthritis through selective inhibition of MMP-13.
    Li NG; Shi ZH; Tang YP; Wang ZJ; Song SL; Qian LH; Qian DW; Duan JA
    Curr Med Chem; 2011; 18(7):977-1001. PubMed ID: 21254976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gumiganghwal-tang ameliorates cartilage destruction via inhibition of matrix metalloproteinase.
    Kim MH; Choi Y; Ahn KS; Um JY; Lee SG; Hahm DH; Yang WM
    J Ethnopharmacol; 2020 Oct; 261():113074. PubMed ID: 32534115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways.
    Milner JM; Elliott SF; Cawston TE
    Arthritis Rheum; 2001 Sep; 44(9):2084-96. PubMed ID: 11592371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation.
    Sondergaard BC; Henriksen K; Wulf H; Oestergaard S; Schurigt U; Bräuer R; Danielsen I; Christiansen C; Qvist P; Karsdal MA
    Osteoarthritis Cartilage; 2006 Aug; 14(8):738-48. PubMed ID: 16563811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
    Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
    Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human articular cartilage.
    Freemont AJ; Byers RJ; Taiwo YO; Hoyland JA
    Ann Rheum Dis; 1999 Jun; 58(6):357-65. PubMed ID: 10340960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage.
    Imai K; Ohta S; Matsumoto T; Fujimoto N; Sato H; Seiki M; Okada Y
    Am J Pathol; 1997 Jul; 151(1):245-56. PubMed ID: 9212749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-37 diminishes proteoglycan loss in human OA cartilage: donor-specific link between IL-37 and MMP-3.
    van Geffen EW; van Caam APM; Schreurs W; van de Loo FA; van Lent PLEM; Koenders MI; Thudium CS; Bay-Jensen AC; Blaney Davidson EN; van der Kraan PM
    Osteoarthritis Cartilage; 2019 Jan; 27(1):148-157. PubMed ID: 30201492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
    Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P
    Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants.
    He Y; Zheng Q; Jiang M; Sun S; Christiansen TG; Kassem M; Karsdal MA; Bay-Jensen AC
    PLoS One; 2015; 10(4):e0122700. PubMed ID: 25909781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis.
    Hu Q; Ecker M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis.
    Xu L; Peng H; Glasson S; Lee PL; Hu K; Ijiri K; Olsen BR; Goldring MB; Li Y
    Arthritis Rheum; 2007 Aug; 56(8):2663-73. PubMed ID: 17665456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of culture conditions and exposure to catabolic stimulators (IL-1 and retinoic acid) on the expression of matrix metalloproteinases (MMPs) and disintegrin metalloproteinases (ADAMs) by articular cartilage chondrocytes.
    Flannery CR; Little CB; Caterson B; Hughes CE
    Matrix Biol; 1999 Jun; 18(3):225-37. PubMed ID: 10429942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.